SGLT2 Inhibitors in Hypertrophic Cardiomyopathy: Emerging Evidence and Putative Mechanisms

Hypertrophic cardiomyopathy (HCM) is the most common inherited myocardial disorder and a major cause of heart failure (HF) and sudden cardiac death. Although sarcomeric gene mutations initiate the disease, increasing evidence identifies oxidative stress, mitochondrial dysfunction, and maladaptive nu...

Fuld beskrivelse

Bibliografiske detaljer

Principais autores:	Khrystyna Ryabenko, Valérie Schini-Kerth, Patrick Ohlmann, Elena Galli
Format:	Artigo
Sprog:	Inglês
Udgivet:	MDPI AG 2026-06-01
Serier:	Biomolecules
Fag:	gliflozines hypertrophic cardiomyopathy inflammation reactive oxygen species sodium–glucose cotransporter 2 inhibitors
Online adgang:	https://www.mdpi.com/2218-273X/16/6/873
Tags:	Tilføj Tag Ingen Tags, Vær først til at tagge denne postø!